Shareholder Shanghai Lujiazui Finance & Trade Zone Development (600663.SH) and its wholly-owned subsidiary collectively increased their stake in the company by 3.4068%.
Shanghai Lujiazui Finance & Trade Zone Development (600663.SH) announced that as of November 12, 2024, the implementation period of this share increase plan has expired and has been completed. From November 14, 2023 to November 12, 2024, the controlling shareholder Shanghai Lujiazui Finance & Trade Zone Development Group and its wholly-owned subsidiary Dongda (Hong Kong) Investment Co., Ltd. (referred to as "Dongda Company") have cumulatively increased the company's A shares by 76.897 million shares and B shares by 94.6398 million shares through the Shanghai Stock Exchange system through centralized bidding trading, totaling 3.4068% of the total share capital of the company. The total amount of the increase is RMB 1.006 billion.
Shenzhen Kangtai Biological Products (300601.SZ): The application for clinical trials of bivalent inactivated enterovirus vaccine (Vero cells) has been accepted.
Beijing SDL Technology (002658.SZ) plans to increase capital by 8 million yuan to its wholly-owned subsidiary at the second level to expand regional business.
RECOMMEND
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com